Dianthus Therapeutics

About Dianthus Therapeutics

Dianthus Therapeutics is a clinical-stage biotechnology company focused on creating novel monoclonal antibodies with enhanced selectivity and potency. Located in New York City and Waltham, Mass., our experienced team of biotech and pharma executives is committed to developing next-generation antibody complement therapeutics. We aim to deliver transformative medicines for individuals suffering from severe autoimmune and inflammatory diseases.